| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
6 companies
Casdin Eli serves as a Director at TNYA and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 10 buys and 0 sells. Those positions are worth an estimated $79.9M at current prices.
Historically, Casdin Eli's trades have earned a middling insider score of 50/100 across 9 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -38.8%.
The biggest single holding is IPSC (~$64.1M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 750,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 | LAB Standard Biotools Inc. | Director, 10% Owner | Buy | 1,200,000 | $2.19 | $2,631,335.00 | New | +18.8% | +12.2% | |
| Jan 31, 2023 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 85,714,285 | $0.35 | $29,999,999.75 | -120.0% | -41.0% | -72.5% | |
| Nov 17, 2022 | TNYA Tenaya Therapeutics, Inc. | Director | Buy | 2,492,042 | $2.60 | $6,479,309.20 | +69.5% | +22.4% | -24.8% | |
| Apr 29, 2022 | WGS Genedx Holdings Corp. | Director | Buy | 11,437,500 | $4.00 | $45,750,000.00 | +228.8% | -25.1% | -87.3% | |
| Aug 3, 2021 | TNYA Tenaya Therapeutics, Inc. | Director, 10% Owner | Buy | 850,000 | $15.00 | $12,750,000.00 | +35.8% | +36.8% | -72.3% | |
| Jul 26, 2021 | ABSI Absci Corp | Director | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +30.1% | -49.7% | -86.4% | |
| Jun 22, 2021 | IPSC Century Therapeutics, Inc. | Director | Buy | 750,000 | $20.00 | $15,000,000.00 | +30.5% | -16.0% | -63.8% |